COCA-COLA EUROPACIFIC PARTNERS Plc current report, Q2 FY2021

Business Context and Reporting Period

This Form 6-K filing by Coca-Cola Europacific Partners Plc (CCEP) is dated May 13, 2021. The document serves as a communication to shareholders regarding the upcoming 2021 Annual General Meeting (AGM) scheduled for May 26, 2021. The filing provides context and management recommendations for specific resolutions where proxy advisory services (Glass Lewis and ISS) have issued conflicting or negative advice.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance and voting matters rather than financial performance reporting.

Material Changes and Governance Issues

The filing addresses three specific resolutions with material governance implications:

  • Resolution 2 (Directors' Remuneration Report): Proxy advisors Glass Lewis and ISS recommend voting "AGAINST" due to concerns over the Remuneration Committee's use of discretion. Specifically, they cite a discretionary cash bonus of £1,490,000 for the CEO and a vesting level of 37% for the CEO's FY2018 Long-Term Incentive Plan (LTIP) despite a formulaic outcome of zero. Advisors also noted the receipt of non-UK government funding.
  • Resolution 23 (Waiver of Mandatory Offer Provisions): This resolution seeks to waive Rule 9 of the Takeover Code to allow share repurchases without triggering a mandatory general offer by Olive Partners, S.A. (Olive), which holds approximately 36.5% of shares. Glass Lewis recommends "FOR," while ISS recommends "AGAINST" citing "creeping control" concerns.
  • Resolution 17 (Re-election of Mario Rotllant Solà): ISS recommends voting "AGAINST" the re-election of Mr. Rotllant Solà to the Remuneration Committee because he is not an independent director. Glass Lewis recommends "FOR," noting his role as a representative of a major shareholder.

Management Commentary and Outlook

Management defends the remuneration decisions as appropriate given the exceptional circumstances of the COVID-19 crisis, emphasizing alignment with the wider workforce and consistent application of discretion (including downward adjustments in prior years). Regarding government support, management clarifies that non-UK schemes (in Germany, Belgium, Norway, and Sweden) totaled less than 0.2% of total employee expenditure and were pre-existing insurance-style schemes, with Swedish support fully repaid.

Regarding the Takeover Code waiver, management states that Olive has confirmed no intention to change its approach or seek control, rendering "creeping control" concerns unfounded. The waiver is necessary to enable share repurchases (Resolutions 26 and 27) to return cash to shareholders.

On the board composition, management asserts that the Remuneration Committee maintains a majority of Independent Non-executive Directors (INEDs) and that having a major shareholder representative on the committee is natural and conflict-free.

Key Facts for Investor Verification

  • Verify the specific terms of the CEO's FY2020 bonus (£1,490,000) and the FY2018 LTIP vesting adjustment in the 2020 Integrated Report.
  • Confirm the total value and repayment status of government support received in Germany, Belgium, Norway, and Sweden.
  • Review Olive Partners, S.A.'s current shareholding percentage (approx. 36.5%) and their formal statement regarding takeover intentions.
  • Check the composition of the Remuneration Committee to confirm the majority of INEDs as claimed by management.
  • Assess the impact of a vote "AGAINST" Resolution 23 on the Company's ability to execute share repurchases.